Key facts
- NORTHSTRIVE FUND II LP filed SCHEDULE 13D for enVVeno Medical Corp Common Stock, par value $0.00001 per share (NVNO).
- Disclosed ownership: 5%.
- Date of event: 20 Feb 2026.
NORTHSTRIVE FUND II LP - 20 Feb 2026 SCHEDULE 13D Report for enVVeno Medical Corp Common Stock, par value $0.00001 per share (NVNO)
- Filing manager
- NORTHSTRIVE FUND II LP
- Reporting owner
- Braeden Lichti
- Beneficially owned shares
- 33,151 shares
- Class ownership
- 5%
- Symbol
- NVNO
- Shares outstanding
- 656,455 shares
- Form type
- SCHEDULE 13D
- Accepted by SEC
- 20 Feb 2026, 09:43:29 UTC
- Event date
- 20 Feb 2026
- Previous filing
- 10 Feb 2026
- SEC filing
- View on sec.gov
Ownership signal
1 signal
Subject security
2 source fields
SEC evidence
5 source fields
Key filing fact
NORTHSTRIVE FUND II LP disclosed 5% ownership in enVVeno Medical Corp Common Stock, par value $0.00001 per share (NVNO) on 20 Feb 2026.
Change
- Previous schedule filing date: 10 Feb 2026.
- Current filing was accepted on 20 Feb 2026, 09:43.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Northstrive Fund II LP | 3.1% | 20,129 | 0 | 20,129 | /s/ Braeden Lichti | Braeden Lichti/Manager | 0002099270 |
| Braeden Lichti | 5% | 33,151 | 0 | 20,129 | /s/ Braeden Lichti | Braeden Lichti | 0001982476 |
CIK / CUSIP context first